Sorrento Therapeutics Inc. | Key People and Executives
Henry H. Ji
Chairman, President & Chief Executive Officer
Yue Wu
Independent Director
David Lemus
Independent Director
Dorman Followwill
Independent Director
David H. Deming
Independent Director
Kim D. Janda
Independent Director
Henry H. Ji
Chairman, President & Chief Executive Officer
Stephen L Klincewicz
VP-Pharmacovigilance & Clinical Operations
Jiong Shao
Chief Financial Officer & Executive Vice President
Robert Knight
Vice President-Clinical Research
Jerome B. Zeldis
Chief Medical Officer & President-Regulatory
George K. Ng
Chief Administrative & Chief Legal Officer, EVP
Hui Li
Vice President-Business Development
Bill Farley
Vice President-Sales & Business Development
Yue Wu
Independent Director
David Lemus
Independent Director
Dorman Followwill
Independent Director
David H. Deming
Independent Director
Kim D. Janda
Independent Director
| Address |
4955 Directors Place
San Diego California 92121
United States
|
|
Employees
|
- |
| Website |
http://www.sorrentotherapeutics.com |
| Updated |
07/08/2019 |
| Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno-oncology antibodies, cellular therapy, cell internalizing antibodies, and antibody drug conjugates. The company was founded by Henry H. |
